Menarini Stemline

Wishing a safe and happy 4th of July to all our Menarini Stemline colleagues, partners, and friends celebrating in the United States! #IndependenceDay #MenariniStemline

For those living with myelofibrosis, the impact is more than just a diagnosis—it’s a daily struggle. Most patients present with two or more debilitating symptoms at diagnosis, ranging from bone pain to extreme fatigue. At Menarini Stemline, we are committed to addressing the unmet needs of the myelofibrosis community. #Myelofibrosis #MenariniStemline

Today is World Blood Donor Day. For individuals facing hematologic malignancies, a readily available blood supply is a lifeline during treatment. At Menarini Stemline, we are deeply grateful to the voluntary donors worldwide who make this essential supportive care possible. #WorldBloodDonorDay #BloodCancer #MenariniStemline

The Menarini Group reports data from the Phase 3 SENTRY trial in myelofibrosis at the European Hematology Association (EHA) 2026 Congress. Read today’s press release here: bit.ly/4vRS7PC #MenariniStemline #EHA2026

Myelofibrosis (MF) is a rare bone marrow cancer that affects approximately 1 in 100,000 people annually, and the median survival after diagnosis is just six years—and it’s why our team remains dedicated to advancing research for those living with orphan blood cancers such as MF. #Myelofibrosis #MenariniStemline

The Menarini Stemline team is looking forward to the European Hematology Association (EHA) 2026 Congress, where we will connect with scientific leaders and share our ongoing commitment to advancing new treatment options for hematologic malignancies. If you are attending #EHA2026, please stop by our booth and meet our team! #MenariniStemline

Today, on National Cancer Survivors Day, we honor the courage and resilience of everyone living with and beyond a cancer diagnosis. At Menarini Stemline, patients are the driving force behind everything we do. Whether we are researching targeted therapies for complex blood cancers or advancing treatments for solid tumors, our goal remains the same: to give patients more time, more hope, and a better quality of life. To the survivors, the caregivers who support them, and the healthcare teams who guide them — we celebrate your strength today and every day. #NCSD2026 #NationalCancerSurvivorsDay #MenariniStemline

That’s a wrap on #ASCO26! Our team is heading home inspired by the groundbreaking discussions on oncology care. It was great to see so many partners, colleagues, and friends in person. #MenariniStemline

The Menarini Group presents new data from the ELEVATE study of its treatment in patients with ER+, HER2- metastatic breast cancer at the 2026 ASCO® Annual Meeting. Read today’s press release here: bit.ly/4wVq3vS #MenariniStemline #ASCO26

Every 27 seconds, someone in the world is diagnosed with blood cancer. Today we shine a light on the patients and families impacted by blood cancer, as we work to bring new treatment options to this community. #WorldBloodCancerDay #MenariniStemline

We’re heading to Chicago for #ASCO26! This is a highlight of the oncology calendar, and we can’t wait to share what we’ve been working on. See you at McCormick Place! #MenariniStemline

On this #MemorialDay, we join our U.S. colleagues in pausing to honor and remember those who gave their lives in service to their country. #MenariniStemline

Clinical research has come a long way since the first recorded trials nearly 300 years ago. Today, we commemorate #InternationalClinicalTrialsDay to honor the evolution of medicine from simple observation to the complex, data-driven global studies that drive our research forward.

Today, we recognize nurses who are the heart of patient care. Happy #InternationalNursesDay to the dedicated professionals who provide both clinical excellence and unwavering compassionate care. Thank you for all that you do. #MenariniStemline

Our team is off to San Antonio for the #ONS2026 Congress. We’re excited to learn from the nursing community who are on the frontlines of oncology patient care. If you’re onsite be sure to visit our booths #903 (Commercial) and #515 (Medical Affairs). #MenariniStemline

We’re leaving #ESMOBreast26 with new insights and strengthened partnerships. Here’s a look at our team on the ground! #MenariniStemline

Today is #WorldOvarianCancerDay. Did you know that more than 300,000 women worldwide are diagnosed with ovarian cancer each year? We join the community in raising awareness today as we work toward a future with better outcomes for patients. #MenariniStemline

We’re heading to #ESMOBreast26 to engage with the global breast cancer community. Looking forward to three days of research updates, clinical discussions, and networking! #MenariniStemline

That’s a wrap on #AACR26! It was an inspiring week of sharing & discussing potential oncology breakthroughs. We're heading home from San Diego energized by the scientific progress that was shared and proud of our team’s dedication to advancing cancer care for patients worldwide.

Happy #AdministrativeProfessionalsDay! Today, we celebrate the expertise & dedication that keeps Menarini Stemline running smoothly every day. We’re especially proud to celebrate this year following our 1st Annual Admin Excellence Day! #MenariniStemline